Livzon Pharmaceutical details extensive A share repurchase activity

Livzon Pharmaceutical Group Inc. submitted its Next Day Disclosure Return on September 4, 2025, detailing changes in its issued H shares and A shares, as well as share repurchases. The company’s H shares, listed on the Exchange, remained unchanged with an opening and closing balance of 299,807,117 ordinary shares as of September 4, 2025.

In contrast, the company has actively repurchased its A shares, which are listed on the main board of the Shenzhen Stock Exchange. A total of 69 separate A share repurchase events were disclosed, ranging from December 25, 2024, to September 4, 2025. These repurchases involved varying quantities of shares, from a low of 1,700 shares to a high of 561,400 shares on a single day. The repurchase prices for these A shares varied, with a range from RMB 34.00 to RMB 41.99 per share.

On September 4, 2025, the company repurchased 72,900 A shares at prices ranging from RMB 40.22 to RMB 41.84, with an aggregate price paid of RMB 2,997,844. As of this date, all 72,900 repurchased shares were intended for cancellation, with no shares held as treasury shares. The total number of issued A shares (excluding treasury shares) remained at 604,293,313 as of September 4, 2025, indicating that these repurchased shares had not yet been canceled.